| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
α7-Acetylcholine Receptor Signaling Reduces Neuroinflammation After Subarachnoid Hemorrhage in Mice
|
Dienel, Ari
|
|
|
18 |
3 |
p. 1891-1904
|
article
|
| 2 |
α7-Acetylcholine Receptor Signaling Reduces Neuroinflammation After Subarachnoid Hemorrhage in Mice
|
Dienel, Ari
|
|
|
18 |
3 |
p. 1891-1904
|
article
|
| 3 |
Activation of Galanin Receptor 1 with M617 Attenuates Neuronal Apoptosis via ERK/GSK-3β/TIP60 Pathway After Subarachnoid Hemorrhage in Rats
|
Shi, Hui
|
|
|
18 |
3 |
p. 1905-1921
|
article
|
| 4 |
Activation of Galanin Receptor 1 with M617 Attenuates Neuronal Apoptosis via ERK/GSK-3β/TIP60 Pathway After Subarachnoid Hemorrhage in Rats
|
Shi, Hui
|
|
|
18 |
3 |
p. 1905-1921
|
article
|
| 5 |
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
|
Frisch, Esther S.
|
|
|
18 |
3 |
p. 1602-1622
|
article
|
| 6 |
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
|
Frisch, Esther S.
|
|
|
18 |
3 |
p. 1602-1622
|
article
|
| 7 |
ASENT2021 Annual Meeting Abstracts
|
|
|
|
18 |
3 |
p. 2134-2151
|
article
|
| 8 |
ASENT2021 Annual Meeting Abstracts
|
|
|
|
18 |
3 |
p. 2134-2151
|
article
|
| 9 |
Association Between Disease-Modifying Therapies Prescribed to Persons with Multiple Sclerosis and Cancer: a WHO Pharmacovigilance Database Analysis
|
Dolladille, Charles
|
|
|
18 |
3 |
p. 1657-1664
|
article
|
| 10 |
Association Between Disease-Modifying Therapies Prescribed to Persons with Multiple Sclerosis and Cancer: a WHO Pharmacovigilance Database Analysis
|
Dolladille, Charles
|
|
|
18 |
3 |
p. 1657-1664
|
article
|
| 11 |
Betulinic Acid Hydroxamate is Neuroprotective and Induces Protein Phosphatase 2A-Dependent HIF-1α Stabilization and Post-transcriptional Dephosphorylation of Prolyl Hydrolase 2
|
Prados, María E.
|
|
|
18 |
3 |
p. 1849-1861
|
article
|
| 12 |
Betulinic Acid Hydroxamate is Neuroprotective and Induces Protein Phosphatase 2A-Dependent HIF-1α Stabilization and Post-transcriptional Dephosphorylation of Prolyl Hydrolase 2
|
Prados, María E.
|
|
|
18 |
3 |
p. 1849-1861
|
article
|
| 13 |
Brain Acetyl-CoA Production and Phosphorylation of Cytoskeletal Proteins Are Targets of CYP46A1 Activity Modulation and Altered Sterol Flux
|
Mast, Natalia
|
|
|
18 |
3 |
p. 2040-2060
|
article
|
| 14 |
Brain Acetyl-CoA Production and Phosphorylation of Cytoskeletal Proteins Are Targets of CYP46A1 Activity Modulation and Altered Sterol Flux
|
Mast, Natalia
|
|
|
18 |
3 |
p. 2040-2060
|
article
|
| 15 |
CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway
|
Ampudia-Mesias, Elisabet
|
|
|
18 |
3 |
p. 1980-1994
|
article
|
| 16 |
CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway
|
Ampudia-Mesias, Elisabet
|
|
|
18 |
3 |
p. 1980-1994
|
article
|
| 17 |
Clarithromycin Ameliorates Early Brain Injury After Subarachnoid Hemorrhage via Suppressing Periostin-Related Pathways in Mice
|
Kanamaru, Hideki
|
|
|
18 |
3 |
p. 1880-1890
|
article
|
| 18 |
Clarithromycin Ameliorates Early Brain Injury After Subarachnoid Hemorrhage via Suppressing Periostin-Related Pathways in Mice
|
Kanamaru, Hideki
|
|
|
18 |
3 |
p. 1880-1890
|
article
|
| 19 |
Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies
|
Brock, Dylan C.
|
|
|
18 |
3 |
p. 1445-1457
|
article
|
| 20 |
Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies
|
Brock, Dylan C.
|
|
|
18 |
3 |
p. 1445-1457
|
article
|
| 21 |
Correction to: CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway
|
Ampudia-Mesias, Elisabet
|
|
|
18 |
3 |
p. 2131
|
article
|
| 22 |
Correction to: CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway
|
Ampudia-Mesias, Elisabet
|
|
|
18 |
3 |
p. 2131
|
article
|
| 23 |
Correction to: Managing Essential Tremor
|
Hopfner, Franziska
|
|
|
18 |
3 |
p. 2132
|
article
|
| 24 |
Correction to: Managing Essential Tremor
|
Hopfner, Franziska
|
|
|
18 |
3 |
p. 2132
|
article
|
| 25 |
Correction to: Multiple Sclerosis: Switching from Natalizumab to Other High-Efficacy Treatments to Mitigate Progressive Multifocal Leukoencephalopathy Risk
|
Hartung, Hans-Peter
|
|
|
18 |
3 |
p. 2126
|
article
|
| 26 |
Correction to: Multiple Sclerosis: Switching from Natalizumab to Other High-Efficacy Treatments to Mitigate Progressive Multifocal Leukoencephalopathy Risk
|
Hartung, Hans-Peter
|
|
|
18 |
3 |
p. 2126
|
article
|
| 27 |
Correction to: Neuronal Adenylyl Cyclase Targeting Central Plasticity for the Treatment of Chronic Pain
|
Li, Xu-Hui
|
|
|
18 |
3 |
p. 2129
|
article
|
| 28 |
Correction to: Neuronal Adenylyl Cyclase Targeting Central Plasticity for the Treatment of Chronic Pain
|
Li, Xu-Hui
|
|
|
18 |
3 |
p. 2129
|
article
|
| 29 |
Correction to: Nutritional Ketosis in Parkinson’s Disease — a Review of Remaining Questions and Insights
|
Choi, Alexander
|
|
|
18 |
3 |
p. 2133
|
article
|
| 30 |
Correction to: Nutritional Ketosis in Parkinson's Disease — a Review of Remaining Questions and Insights
|
Choi, Alexander
|
|
|
18 |
3 |
p. 2133
|
article
|
| 31 |
Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study
|
Rudnicki, Stacy A.
|
|
|
18 |
3 |
p. 2130
|
article
|
| 32 |
Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study
|
Rudnicki, Stacy A.
|
|
|
18 |
3 |
p. 2130
|
article
|
| 33 |
Correction to: The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis
|
Bose, Poulomee
|
|
|
18 |
3 |
p. 2128
|
article
|
| 34 |
Correction to: The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis
|
Bose, Poulomee
|
|
|
18 |
3 |
p. 2128
|
article
|
| 35 |
Correction to: The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders
|
Schwarz, Adam J.
|
|
|
18 |
3 |
p. 2127
|
article
|
| 36 |
Correction to: The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders
|
Schwarz, Adam J.
|
|
|
18 |
3 |
p. 2127
|
article
|
| 37 |
Development of EQ-6, a Novel Analogue of Ethoxyquin to Prevent Chemotherapy-Induced Peripheral Neuropathy
|
Cetinkaya-Fisgin, Aysel
|
|
|
18 |
3 |
p. 2061-2072
|
article
|
| 38 |
Development of EQ-6, a Novel Analogue of Ethoxyquin to Prevent Chemotherapy-Induced Peripheral Neuropathy
|
Cetinkaya-Fisgin, Aysel
|
|
|
18 |
3 |
p. 2061-2072
|
article
|
| 39 |
Diagnostic Considerations in the Epilepsies—Testing Strategies, Test Type Advantages, and Limitations
|
Chen, Wei-Liang
|
|
|
18 |
3 |
p. 1468-1477
|
article
|
| 40 |
Diagnostic Considerations in the Epilepsies—Testing Strategies, Test Type Advantages, and Limitations
|
Chen, Wei-Liang
|
|
|
18 |
3 |
p. 1468-1477
|
article
|
| 41 |
DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases
|
Zhang, Nan
|
|
|
18 |
3 |
p. 1710-1728
|
article
|
| 42 |
DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases
|
Zhang, Nan
|
|
|
18 |
3 |
p. 1710-1728
|
article
|
| 43 |
Donepezil Protects Against Doxorubicin-Induced Chemobrain in Rats via Attenuation of Inflammation and Oxidative Stress Without Interfering With Doxorubicin Efficacy
|
Ongnok, Benjamin
|
|
|
18 |
3 |
p. 2107-2125
|
article
|
| 44 |
Donepezil Protects Against Doxorubicin-Induced Chemobrain in Rats via Attenuation of Inflammation and Oxidative Stress Without Interfering With Doxorubicin Efficacy
|
Ongnok, Benjamin
|
|
|
18 |
3 |
p. 2107-2125
|
article
|
| 45 |
Dravet Syndrome: Novel Approaches for the Most Common Genetic Epilepsy
|
Isom, Lori L.
|
|
|
18 |
3 |
p. 1524-1534
|
article
|
| 46 |
Dravet Syndrome: Novel Approaches for the Most Common Genetic Epilepsy
|
Isom, Lori L.
|
|
|
18 |
3 |
p. 1524-1534
|
article
|
| 47 |
Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis
|
Fiscon, Giulia
|
|
|
18 |
3 |
p. 1678-1691
|
article
|
| 48 |
Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis
|
Fiscon, Giulia
|
|
|
18 |
3 |
p. 1678-1691
|
article
|
| 49 |
Effect of Pharmacological Inhibition of Fat-Mass and Obesity-Associated Protein on Nerve Trauma-Induced Pain Hypersensitivities
|
Zheng, Bi-Xin
|
|
|
18 |
3 |
p. 1995-2007
|
article
|
| 50 |
Effect of Pharmacological Inhibition of Fat-Mass and Obesity-Associated Protein on Nerve Trauma-Induced Pain Hypersensitivities
|
Zheng, Bi-Xin
|
|
|
18 |
3 |
p. 1995-2007
|
article
|
| 51 |
Electrophysiological Biomarkers in Genetic Epilepsies
|
Armstrong, Caren
|
|
|
18 |
3 |
p. 1458-1467
|
article
|
| 52 |
Electrophysiological Biomarkers in Genetic Epilepsies
|
Armstrong, Caren
|
|
|
18 |
3 |
p. 1458-1467
|
article
|
| 53 |
Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome
|
Copping, Nycole A.
|
|
|
18 |
3 |
p. 1535-1547
|
article
|
| 54 |
Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome
|
Copping, Nycole A.
|
|
|
18 |
3 |
p. 1535-1547
|
article
|
| 55 |
Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells
|
Schwichtenberg, Svenja C.
|
|
|
18 |
3 |
p. 1783-1797
|
article
|
| 56 |
Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells
|
Schwichtenberg, Svenja C.
|
|
|
18 |
3 |
p. 1783-1797
|
article
|
| 57 |
FRET-Based Screening Identifies p38 MAPK and PKC Inhibition as Targets for Prevention of Seeded α-Synuclein Aggregation
|
Svanbergsson, Alexander
|
|
|
18 |
3 |
p. 1692-1709
|
article
|
| 58 |
FRET-Based Screening Identifies p38 MAPK and PKC Inhibition as Targets for Prevention of Seeded α-Synuclein Aggregation
|
Svanbergsson, Alexander
|
|
|
18 |
3 |
p. 1692-1709
|
article
|
| 59 |
Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies?
|
Carpenter, Jenna C.
|
|
|
18 |
3 |
p. 1515-1523
|
article
|
| 60 |
Gene Editing and Modulation: the Holy Grail for the Genetic Epilepsies?
|
Carpenter, Jenna C.
|
|
|
18 |
3 |
p. 1515-1523
|
article
|
| 61 |
Haploinsufficiency, Dominant Negative, and Gain-of-Function Mechanisms in Epilepsy: Matching Therapeutic Approach to the Pathophysiology
|
Carvill, Gemma L.
|
|
|
18 |
3 |
p. 1500-1514
|
article
|
| 62 |
Haploinsufficiency, Dominant Negative, and Gain-of-Function Mechanisms in Epilepsy: Matching Therapeutic Approach to the Pathophysiology
|
Carvill, Gemma L.
|
|
|
18 |
3 |
p. 1500-1514
|
article
|
| 63 |
Histone Mark Profiling in Pediatric Astrocytomas Reveals Prognostic Significance of H3K9 Trimethylation and Histone Methyltransferase SUV39H1
|
Klonou, Alexia
|
|
|
18 |
3 |
p. 2073-2090
|
article
|
| 64 |
Histone Mark Profiling in Pediatric Astrocytomas Reveals Prognostic Significance of H3K9 Trimethylation and Histone Methyltransferase SUV39H1
|
Klonou, Alexia
|
|
|
18 |
3 |
p. 2073-2090
|
article
|
| 65 |
In Vivo Wireless Brain Stimulation via Non-invasive and Targeted Delivery of Magnetoelectric Nanoparticles
|
Nguyen, Tyler
|
|
|
18 |
3 |
p. 2091-2106
|
article
|
| 66 |
In Vivo Wireless Brain Stimulation via Non-invasive and Targeted Delivery of Magnetoelectric Nanoparticles
|
Nguyen, Tyler
|
|
|
18 |
3 |
p. 2091-2106
|
article
|
| 67 |
KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson’s Disease
|
Nam, Min-Ho
|
|
|
18 |
3 |
p. 1729-1747
|
article
|
| 68 |
KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's Disease
|
Nam, Min-Ho
|
|
|
18 |
3 |
p. 1729-1747
|
article
|
| 69 |
Loss of CC2D1A in Glutamatergic Neurons Results in Autistic-Like Features in Mice
|
Yang, Cheng-Yi
|
|
|
18 |
3 |
p. 2021-2039
|
article
|
| 70 |
Loss of CC2D1A in Glutamatergic Neurons Results in Autistic-Like Features in Mice
|
Yang, Cheng-Yi
|
|
|
18 |
3 |
p. 2021-2039
|
article
|
| 71 |
Medications for Multiple Sclerosis and Risk of Malignancy: What Next?
|
Horton, Daniel B.
|
|
|
18 |
3 |
p. 1650-1653
|
article
|
| 72 |
Medications for Multiple Sclerosis and Risk of Malignancy: What Next?
|
Horton, Daniel B.
|
|
|
18 |
3 |
p. 1650-1653
|
article
|
| 73 |
Mesenchymal Stem Cell (MSC)–Derived Extracellular Vesicles Protect from Neonatal Stroke by Interacting with Microglial Cells
|
Pathipati, Praneeti
|
|
|
18 |
3 |
p. 1939-1952
|
article
|
| 74 |
Mesenchymal Stem Cell (MSC)–Derived Extracellular Vesicles Protect from Neonatal Stroke by Interacting with Microglial Cells
|
Pathipati, Praneeti
|
|
|
18 |
3 |
p. 1939-1952
|
article
|
| 75 |
Multiple Sclerosis: Switching from Natalizumab to Other High-Efficacy Treatments to Mitigate Progressive Multifocal Leukoencephalopathy Risk
|
Hartung, Hans-Peter
|
|
|
18 |
3 |
p. 1654-1656
|
article
|
| 76 |
Multiple Sclerosis: Switching from Natalizumab to Other High-Efficacy Treatments to Mitigate Progressive Multifocal Leukoencephalopathy Risk
|
Hartung, Hans-Peter
|
|
|
18 |
3 |
p. 1654-1656
|
article
|
| 77 |
N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice
|
Bottemanne, Pauline
|
|
|
18 |
3 |
p. 1815-1833
|
article
|
| 78 |
N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice
|
Bottemanne, Pauline
|
|
|
18 |
3 |
p. 1815-1833
|
article
|
| 79 |
Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic Encephalopathies
|
Palmer, Elizabeth E.
|
|
|
18 |
3 |
p. 1432-1444
|
article
|
| 80 |
Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic Encephalopathies
|
Palmer, Elizabeth E.
|
|
|
18 |
3 |
p. 1432-1444
|
article
|
| 81 |
Network Substrates of Centromedian Nucleus Deep Brain Stimulation in Generalized Pharmacoresistant Epilepsy
|
Torres Diaz, Cristina V.
|
|
|
18 |
3 |
p. 1665-1677
|
article
|
| 82 |
Network Substrates of Centromedian Nucleus Deep Brain Stimulation in Generalized Pharmacoresistant Epilepsy
|
Torres Diaz, Cristina V.
|
|
|
18 |
3 |
p. 1665-1677
|
article
|
| 83 |
Neurokinin Receptor 1 (NK1R) Antagonist Aprepitant Enhances Hematoma Clearance by Regulating Microglial Polarization via PKC/p38MAPK/NFκB Pathway After Experimental Intracerebral Hemorrhage in Mice
|
Jin, Peng
|
|
|
18 |
3 |
p. 1922-1938
|
article
|
| 84 |
Neurokinin Receptor 1 (NK1R) Antagonist Aprepitant Enhances Hematoma Clearance by Regulating Microglial Polarization via PKC/p38MAPK/NFκB Pathway After Experimental Intracerebral Hemorrhage in Mice
|
Jin, Peng
|
|
|
18 |
3 |
p. 1922-1938
|
article
|
| 85 |
Novel Approaches to Prevent Epileptogenesis After Traumatic Brain Injury
|
Dulla, Chris G.
|
|
|
18 |
3 |
p. 1582-1601
|
article
|
| 86 |
Novel Approaches to Prevent Epileptogenesis After Traumatic Brain Injury
|
Dulla, Chris G.
|
|
|
18 |
3 |
p. 1582-1601
|
article
|
| 87 |
Novel Therapeutics for Neonatal Seizures
|
Ziobro, Julie M.
|
|
|
18 |
3 |
p. 1564-1581
|
article
|
| 88 |
Novel Therapeutics for Neonatal Seizures
|
Ziobro, Julie M.
|
|
|
18 |
3 |
p. 1564-1581
|
article
|
| 89 |
Nutritional Ketosis in Parkinson’s Disease — a Review of Remaining Questions and Insights
|
Choi, Alexander
|
|
|
18 |
3 |
p. 1637-1649
|
article
|
| 90 |
Nutritional Ketosis in Parkinson's Disease — a Review of Remaining Questions and Insights
|
Choi, Alexander
|
|
|
18 |
3 |
p. 1637-1649
|
article
|
| 91 |
Oleoylethanolamide Delays the Dysfunction and Death of Purkinje Cells and Ameliorates Behavioral Defects in a Mouse Model of Cerebellar Neurodegeneration
|
Pérez-Martín, Ester
|
|
|
18 |
3 |
p. 1748-1767
|
article
|
| 92 |
Oleoylethanolamide Delays the Dysfunction and Death of Purkinje Cells and Ameliorates Behavioral Defects in a Mouse Model of Cerebellar Neurodegeneration
|
Pérez-Martín, Ester
|
|
|
18 |
3 |
p. 1748-1767
|
article
|
| 93 |
Pain Relieving and Neuroprotective Effects of Non-opioid Compound, DDD-028, in the Rat Model of Paclitaxel-Induced Neuropathy
|
Micheli, Laura
|
|
|
18 |
3 |
p. 2008-2020
|
article
|
| 94 |
Pain Relieving and Neuroprotective Effects of Non-opioid Compound, DDD-028, in the Rat Model of Paclitaxel-Induced Neuropathy
|
Micheli, Laura
|
|
|
18 |
3 |
p. 2008-2020
|
article
|
| 95 |
Precision Therapy for Epilepsy Related to Brain Malformations
|
D’Gama, Alissa M.
|
|
|
18 |
3 |
p. 1548-1563
|
article
|
| 96 |
Precision Therapy for Epilepsy Related to Brain Malformations
|
D'Gama, Alissa M.
|
|
|
18 |
3 |
p. 1548-1563
|
article
|
| 97 |
Precision Treatments in Epilepsy
|
Demarest, Scott
|
|
|
18 |
3 |
p. 1429-1431
|
article
|
| 98 |
Precision Treatments in Epilepsy
|
Demarest, Scott
|
|
|
18 |
3 |
p. 1429-1431
|
article
|
| 99 |
Rational Small Molecule Treatment for Genetic Epilepsies
|
Goldberg, Ethan M.
|
|
|
18 |
3 |
p. 1490-1499
|
article
|
| 100 |
Rational Small Molecule Treatment for Genetic Epilepsies
|
Goldberg, Ethan M.
|
|
|
18 |
3 |
p. 1490-1499
|
article
|
| 101 |
Reconditioning the Neurogenic Niche of Adult Non-human Primates by Antisense Oligonucleotide-Mediated Attenuation of TGFβ Signaling
|
Peters, Sebastian
|
|
|
18 |
3 |
p. 1963-1979
|
article
|
| 102 |
Reconditioning the Neurogenic Niche of Adult Non-human Primates by Antisense Oligonucleotide-Mediated Attenuation of TGFβ Signaling
|
Peters, Sebastian
|
|
|
18 |
3 |
p. 1963-1979
|
article
|
| 103 |
Sapropterin (BH4) Aggravates Autoimmune Encephalomyelitis in Mice
|
Schmitz, Katja
|
|
|
18 |
3 |
p. 1862-1879
|
article
|
| 104 |
Sapropterin (BH4) Aggravates Autoimmune Encephalomyelitis in Mice
|
Schmitz, Katja
|
|
|
18 |
3 |
p. 1862-1879
|
article
|
| 105 |
Screening Platforms for Genetic Epilepsies—Zebrafish, iPSC-Derived Neurons, and Organoids
|
Shcheglovitov, Aleksandr
|
|
|
18 |
3 |
p. 1478-1489
|
article
|
| 106 |
Screening Platforms for Genetic Epilepsies—Zebrafish, iPSC-Derived Neurons, and Organoids
|
Shcheglovitov, Aleksandr
|
|
|
18 |
3 |
p. 1478-1489
|
article
|
| 107 |
Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders
|
Mausner-Fainberg, Karin
|
|
|
18 |
3 |
p. 1798-1814
|
article
|
| 108 |
Specific Blockade of Bone Morphogenetic Protein-2/4 Induces Oligodendrogenesis and Remyelination in Demyelinating Disorders
|
Mausner-Fainberg, Karin
|
|
|
18 |
3 |
p. 1798-1814
|
article
|
| 109 |
Targeting Neuromyelitis Optica Pathogenesis: Results from Randomized Controlled Trials of Biologics
|
Cacciaguerra, Laura
|
|
|
18 |
3 |
p. 1623-1636
|
article
|
| 110 |
Targeting Neuromyelitis Optica Pathogenesis: Results from Randomized Controlled Trials of Biologics
|
Cacciaguerra, Laura
|
|
|
18 |
3 |
p. 1623-1636
|
article
|
| 111 |
The Antipsychotic Drug Clozapine Suppresses the RGS4 Polyubiquitylation and Proteasomal Degradation Mediated by the Arg/N-Degron Pathway
|
Jeon, Jun Hyoung
|
|
|
18 |
3 |
p. 1768-1782
|
article
|
| 112 |
The Antipsychotic Drug Clozapine Suppresses the RGS4 Polyubiquitylation and Proteasomal Degradation Mediated by the Arg/N-Degron Pathway
|
Jeon, Jun Hyoung
|
|
|
18 |
3 |
p. 1768-1782
|
article
|
| 113 |
Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis
|
Gharagozloo, Marjan
|
|
|
18 |
3 |
p. 1834-1848
|
article
|
| 114 |
Therapeutic Potential of a Novel Glucagon-like Peptide-1 Receptor Agonist, NLY01, in Experimental Autoimmune Encephalomyelitis
|
Gharagozloo, Marjan
|
|
|
18 |
3 |
p. 1834-1848
|
article
|
| 115 |
Transcutaneous Spinal Neuromodulation Reorganizes Neural Networks in Patients with Cerebral Palsy
|
Gad, Parag
|
|
|
18 |
3 |
p. 1953-1962
|
article
|
| 116 |
Transcutaneous Spinal Neuromodulation Reorganizes Neural Networks in Patients with Cerebral Palsy
|
Gad, Parag
|
|
|
18 |
3 |
p. 1953-1962
|
article
|
Journal description